Targeted Sensory Reinnervation (TSR) in Hand Amputation

Real-World Treatment Patterns, Clinical Outcomes of a Novel Method in Targeted Sensory Re-innervation in Hand Amputation by Using and Reactivation of Existing Nerves to Treat and Prevent Phantom Pain A Retrospective, Non-interventional, Multinational, Multi-center Retrospective Data Analysis to Describe the Treatment Patterns and Clinical Outcomes in a Novel Method in Targeted Sensory Reinnervation in Patients With Hand Amputation by Using and Reactivation of Existing Nerves to Treat and Prevent Phantom Pain.

If a person has to have a part of their body amputated, in this case their hand, the patient then lacks information about the missing limb, which in many cases leads to pain that severely restricts their quality of life and participation in everyday life.

This is usually phantom and/or neuroma pain. Phantom pain is usually caused by many different mechanisms and occurs in 80-90% of patients.

Pain caused by terminal neuromas affects 13-32% of amputees and manifests itself as residual limb pain.

A neuroma itself is a benign lump that can develop at the site of the defect after a nerve has been severed (neurectomy).

In some cases the impairment is so severe that prosthetic tolerance, functional independence and quality of life can be severely affected.

Numerous treatment options for these types of pain are far from satisfactory for many patients and remain a major challenge for both the clinician and the person affected.

It is often no longer possible for the patients to pursue a profession or hobby due to the pain as well as due to the pain medication required and its possible side effects.

Surgical intervention can therefore be considered for patients who do not (or no longer) respond to conservative pain treatment.

In recent years, many surgical approaches have been introduced to treat or prevent post-amputee pain.

One of these methods can make it possible to create an authentic feeling of the missing limb and thus reduce or eliminate phantom pain by means of targeted sensory reinnervation (TSR) of the lost body part.

Sensory reinnervation means that a nerve which enables a (sensory) perception associated with a sense is "redirected" to a new area of the body and can therefore fulfil at least part of its task again.

In this case, an authentic feeling of the lost body part.

The aim of this retrospective data-analysis is to evaluate data from patients with hand amputation (planned surgery or caused by accident/infection..) who have undergone TSR surgery to treat or prevent phantom and neuro-pain with regard to different parameters.

Study Overview

Study Type

Observational

Enrollment (Actual)

3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kärnten
      • Klagenfurt, Kärnten, Austria, 9020
        • AUVA Hospital Klagenfurt
      • Brixen, Italy, 39042
        • Brixsana Private Clinic Center for Plastic, Aesthetic and Reconstructive Surgery with Hand Surgery Competence Center for Bionic Prosthetics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients with upper limb amputation (planned as well as accident related) with treatment resistant (phantom-and-or neuroma) pain.

Description

Inclusion Criteria:

  • Patients with amputations of the hand
  • Patient with programmed hand amputation
  • Patients with treatment-resistant pain
  • Patients with treatment-resistant phantom- and neuroma pain
  • Patients with performed TSR Surgery
  • Aged at least 18 years
  • Patient must be alive at the time of medical record review

Exclusion Criteria:

  • Patients enrolled in another interventional clinical trial
  • An injured skin area for reinnervation at the volar side of the forearm, as well as an injured median or ulnar nerve.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effects in use and reinervation (begin of sensation, localisation of sensation on the hand..)
Time Frame: 01.09.2020 - 31.03.2022
Describtion of the effect of the use and reactivation of existing nerves in connection with the TSR in the delvelopment of phantom pain
01.09.2020 - 31.03.2022

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Date of targeted sensory reinervation (TSR)
Time Frame: 01.09.2020 - 31.03.2022
Date, surgery to reinervate the nerve was performed
01.09.2020 - 31.03.2022
Start date and type of Physiotherapy
Time Frame: 01.09.2020 - 31.03.2022
Type of physiotherapy: ultrasound, vibrational therapy, exercise...
01.09.2020 - 31.03.2022
Time between amputation and surgery
Time Frame: 01.09.2020 - 31.03.2022
days, months or years
01.09.2020 - 31.03.2022
Cause of injury or disease
Time Frame: 01.09.2020 - 31.03.2022
for example: accident
01.09.2020 - 31.03.2022
presence of phantom pain -and neuroma pain
Time Frame: 01.09.2020 - 31.03.2022
patient survey and scale
01.09.2020 - 31.03.2022
concomittant treatment post TSR
Time Frame: 01.09.2020 - 31.03.2022
dosage, indication and active agent of medication will be documented
01.09.2020 - 31.03.2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexander Gardetto, Doz.Dr, Brixsana Private Clinic
  • Principal Investigator: Smekal Vinzenz, Dr., AUVA Hospital Klagenfurt, Department of Orthopaedics and Traumatology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2022

Primary Completion (Actual)

August 2, 2023

Study Completion (Actual)

August 2, 2023

Study Registration Dates

First Submitted

January 23, 2024

First Submitted That Met QC Criteria

January 31, 2024

First Posted (Actual)

February 8, 2024

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

January 31, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on targeted sensory reinervation

3
Subscribe